Related Experiment Video

Updated: Jul 7, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma

Taranjit S Gujral1, Wendy van Veelen, Douglas S Richardson

  • 1Division of Cancer Biology and Genetics, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.

Cancer Research
|March 5, 2008
PubMed

Insights

The RET receptor tyrosine kinase directly phosphorylates beta-catenin, promoting its nuclear accumulation and driving thyroid cancer growth and metastasis. Inhibiting this beta-catenin-RET pathway reduces tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The RET receptor tyrosine kinase is crucial for cell functions but its oncogenic activation in thyroid cancer is not fully understood.
  • Nuclear beta-catenin accumulation is observed in thyroid tumors, hinting at a novel signaling role.

Purpose of the Study:

  • To elucidate the molecular mechanisms of RET-mediated oncogenesis in thyroid cancer.
  • To investigate the role of the beta-catenin signaling pathway in RET-driven thyroid tumorigenesis.

Main Methods:

  • Investigated RET and beta-catenin interaction using biochemical assays.
  • Analyzed nuclear beta-catenin localization in patient tumor samples.
  • Assessed the impact of beta-catenin inhibition on RET-mediated cancer cell behaviors in vitro and in vivo.

Main Results:

  • RET directly binds and tyrosine phosphorylates beta-catenin.
  • Phosphorylated beta-catenin escapes degradation, leading to nuclear accumulation.
  • Nuclear beta-catenin drives RET-dependent transcriptional programs.
  • Down-regulation of beta-catenin activity significantly reduced RET-mediated proliferation, colony formation, and tumor growth.

Conclusions:

  • A novel beta-catenin-RET kinase pathway is identified as critical for thyroid carcinoma development and metastasis.
  • Targeting this pathway holds potential for therapeutic intervention in thyroid cancer.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...